BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12237922)

  • 1. Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.
    Jänne PA; Freidlin B; Saxman S; Johnson DH; Livingston RB; Shepherd FA; Johnson BE
    Cancer; 2002 Oct; 95(7):1528-38. PubMed ID: 12237922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress.
    Chute JP; Chen T; Feigal E; Simon R; Johnson BE
    J Clin Oncol; 1999 Jun; 17(6):1794-801. PubMed ID: 10561217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?
    Schreiber D; Rineer J; Weedon J; Vongtama D; Wortham A; Kim A; Han P; Choi K; Rotman M
    Cancer; 2010 Mar; 116(5):1350-7. PubMed ID: 20082453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database.
    Lally BE; Geiger AM; Urbanic JJ; Butler JM; Wentworth S; Perry MC; Wilson LD; Horton JK; Detterbeck FC; Miller AA; Thomas CR; Blackstock AW
    Lung Cancer; 2009 May; 64(2):226-31. PubMed ID: 18835059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
    Patel S; Macdonald OK; Suntharalingam M
    Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
    Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.
    Hotta K; Fujiwara Y; Matsuo K; Suzuki T; Kiura K; Tabata M; Takigawa N; Ueoka H; Tanimoto M
    Cancer; 2007 Mar; 109(5):939-48. PubMed ID: 17285602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing outcomes of cancer care: lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996-July 2000.
    Ellis PM; Delaney G; Della-Fiorentina S; Moylan E
    Australas Radiol; 2004 Sep; 48(3):364-70. PubMed ID: 15344988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994.
    Lebitasy MP; Hédelin G; Purohit A; Moreau L; Klinzig F; Quoix E
    Br J Cancer; 2001 Sep; 85(6):808-15. PubMed ID: 11556829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.
    Govindan R; Page N; Morgensztern D; Read W; Tierney R; Vlahiotis A; Spitznagel EL; Piccirillo J
    J Clin Oncol; 2006 Oct; 24(28):4539-44. PubMed ID: 17008692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
    Wakelee HA; Bernardo P; Johnson DH; Schiller JH
    Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
    Lorigan P; Woll PJ; O'Brien ME; Ashcroft LF; Sampson MR; Thatcher N
    J Natl Cancer Inst; 2005 May; 97(9):666-74. PubMed ID: 15870437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
    Schild SE; Bonner JA; Hillman S; Kozelsky TF; Vigliotti AP; Marks RS; Graham DL; Soori GS; Kugler JW; Tenglin RC; Wender DB; Adjei A
    J Clin Oncol; 2007 Jul; 25(21):3124-9. PubMed ID: 17634491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy patterns of care study in lung carcinoma.
    Movsas B; Moughan J; Komaki R; Choy H; Byhardt R; Langer C; Goldberg M; Graham M; Ettinger D; Johnstone D; Abrams R; Munden R; Starkschall G; Owen J
    J Clin Oncol; 2003 Dec; 21(24):4553-9. PubMed ID: 14597743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results.
    Breathnach OS; Freidlin B; Conley B; Green MR; Johnson DH; Gandara DR; O'Connell M; Shepherd FA; Johnson BE
    J Clin Oncol; 2001 Mar; 19(6):1734-42. PubMed ID: 11251004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
    Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
    Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in patterns of care for limited-stage small-cell lung cancer: results of the 99-01 patterns of care study-a nationwide survey in Japan.
    Uno T; Sumi M; Ishihara Y; Numasaki H; Mitsumori M; Teshima T;
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):414-9. PubMed ID: 18164865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer.
    Berthelet E; Truong PT; Lesperance M; Lim JT; Wai ES; MacNeil MV; Liu M; Joe H; Olivotto IA
    Am J Clin Oncol; 2006 Feb; 29(1):21-6. PubMed ID: 16462498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.